A 2240 (see companion bill S 1667) – New Jersey
Status: In ProcessYear Introduced: 2022
Link: https://www.njleg.state.nj.us/bill-search/2022/A2240
Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found